Broadfin Capital, LLC Last Quarter Change: USA Options, New

Broadfin Capital, LLC quarter change: USA Options, New

In put and call options, at their filed underlying value (listed in the US), from the quarter ended 2016-06-30 to 2016-09-30, Broadfin Capital, LLC opened 3 positions, added to 1, reduced 0, sold out of 2 and left 0 unchanged. The largest increase in value was XBI (+$33,145,000); the largest decrease was SPY (-$115,211,000).

XBI: Country of operation —; Class S&P BIOTECH · Put; Shares 2016-06-30 0; Shares 2016-09-30 500,000.
HRTX: Country of operation United States; Class COM · Call; Shares 2016-06-30 0; Shares 2016-09-30 300,000.
PCRX: Country of operation United States; Class COM · Call; Shares 2016-06-30 0; Shares 2016-09-30 150,000.

Two Form 13F-HR filings compared (SEC CIK 1511901): 2016-06-30 (filed 2016-08-15) and 2016-09-30 (filed 2016-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.

Stock	Country of operation	Class	Shares 2016-09-30	Share change	Value 2016-06-30	Value 2016-09-30	Value change
XBI SPDR SERIES TRUST		S&P BIOTECH · Put	500,000	+500,000	$0	$33,145,000	+$33,145,000
HRTX HERON THERAPEUTICS INC	United States	COM · Call	300,000	+300,000	$0	$5,169,000	+$5,169,000
PCRX PACIRA PHARMACEUTICALS INC	United States	COM · Call	150,000	+150,000	$0	$5,133,000	+$5,133,000

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet